I agree that firm evidence of cold hard cash will get the herd excited but yesterdays announcement was not the platform for such information. I can understand the frustration from long term holders who have been waiting a few years for Ropren to hit the shelves but the wait looks to be over. The company can no longer make us wait with whats been released to the market without share holders dumping. We have been told about the Russian sales commencing soon now we are told a commitment for quarterly sales has been made so it's time to deliver on actual numbers or the share crashes. The directors should know this so they wouldn't make those announcements unless they truly believe it's all about to happen. That's the way I see it but perhaps I'm naive.
SLA Price at posting:
32.9¢ Sentiment: LT Buy Disclosure: Held
